A multidisciplinary team of researches specialized on Biotechnology, Biomedicine, Science and Environmental sciences, will research in new processes for the biosimilars production.
Researches of the UCA will collaborate with the biopharmaceutical company Curaxys to develop therapeutic proteins for cancer treatment.
Curaxys is the new company specialized in the production of biosimilars medicines. It is an independent private company, located on the technological park of Cadiz Spain). The new venture is focuses in the development of new technological platforms.
Curaxys is a biotechnology company that researches, develops, produces and marketing biosimilars products using new biotechnology process and offering ...
Satisfied Users & 
Approved Press Releases
